Strategic integration of 3D Cell culture and regenerative biomedical technologies in India's biomedical ecosystem: Aligning with the global transition toward human-relevant drug development.

Dandekar P, Jain R, Parvatam S, Mehta V

Open source

DOI: 10.1016/j.namjnl.2026.100116
Published: 2026
Container: NAM journal
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.namjnl.2026.100116,
  title = {Strategic integration of 3D Cell culture and regenerative biomedical technologies in India's biomedical ecosystem: Aligning with the global transition toward human-relevant drug development.},
  author = {Dandekar P and Jain R and Parvatam S and Mehta V},
  year = {2026},
  journal = {NAM journal},
  doi = {10.1016/j.namjnl.2026.100116},
  url = {https://doi.org/10.1016/j.namjnl.2026.100116}
}

RIS

TY  - JOUR
TI  - Strategic integration of 3D Cell culture and regenerative biomedical technologies in India's biomedical ecosystem: Aligning with the global transition toward human-relevant drug development.
AU  - Dandekar P
AU  - Jain R
AU  - Parvatam S
AU  - Mehta V
PY  - 2026
JO  - NAM journal
DO  - 10.1016/j.namjnl.2026.100116
UR  - https://doi.org/10.1016/j.namjnl.2026.100116
ER  -

APA

P, D., R, J., S, P., & V, M. (2026). Strategic integration of 3D Cell culture and regenerative biomedical technologies in India's biomedical ecosystem: Aligning with the global transition toward human-relevant drug development.. NAM journal. https://doi.org/10.1016/j.namjnl.2026.100116

Source records

pubmed · retrieved 2026-09-26T06:52:11.136Z
europe-pmc · retrieved 2026-09-26T06:52:11.162Z
doaj · retrieved 2026-09-26T06:52:11.137Z